documents: FDA-2019-N-2175-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-N-2175-0003 | FDA | FDA-2019-N-2175 | Reference 1 - Flynn K.E, C.L. Hahn, J.M. Kramer, et al. (2013), “Using Central IRBs for Multicenter Clinical Trials in the United States,” PLOS ONE 8(1): e54999. RE Institutional Review Boards; Cooperative Research | Supporting & Related Material | Background Material | 2022-09-28T04:00:00Z | 2022 | 9 | 2022-09-28T19:18:31Z | 0 | 0 | 0900006485379fd7 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref